CMPX Stock Analysis: Buy, Sell, or Hold?
CMPX - Compass Therapeutics, Inc. Common Stock
$1.87
0.01 (0.54%)
▲
5d:
+2.19%
30d:
-68.83%
90d:
-70.74%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Distribution
CMPX is up 9.4% this week, but smart money is buying puts. Top strike: $2 2026-06-18 with 11,041 OI. Put ratio: 64% View Scanner →
Strength: 6.1/10
Get Alerted When CMPX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CMPX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CMPX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CMPX is currently trading at $1.87, which is considered slightly low relative to its 30-day fair value range of $1.84 to $5.49.
Technical Outlook: Technically, CMPX is in a strong uptrend. Immediate support is located at $1.75, while resistance sits at $2.02.
Market Sentiment: CMPX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.58 (+469.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CMPX is in a strong uptrend. Immediate support is located at $1.75, while resistance sits at $2.02.
Market Sentiment: CMPX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.58 (+469.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.84 -
$5.49
Company Quality Score
59/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 469.0% below Wall St target ($10.58)
Trading Range Analysis
30-Day Trading Range
$1.84 -
$5.49
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.75
Resistance Level
$2.02
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.33
Wall Street Target
$10.58
(+469.0%)
Share & Embed Analysis
Last updated: May 18, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
Data refreshes hourly during market hours. Next update: 11:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMPX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 57 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 55 HOLD |
